HIV vaccines represent a crucial frontier in the ongoing fight against HIV/AIDS. Researchers worldwide are dedicated to developing effective vaccines that can prevent HIV infection or control the virus in individuals already exposed. These vaccines aim to stimulate the immune system to recognize and neutralize the virus, preventing its replication and transmission. Numerous vaccine candidates have undergone clinical trials, demonstrating varying levels of effectiveness. While no licensed HIV vaccine exists yet, ongoing research continues to advance our understanding and prospects for an effective preventive vaccine. The development of an HIV vaccine remains a global priority, offering immense hope in curbing the spread of this persistent and devastating virus.
Important Alert:
X
Title : Optimizing vaccine trial design: A novel promising zone approach with adaptive Interim analysis for managing delayed effects
Depeng Jiang, University of Manitoba, Canada
Title : Why Antimicrobial Resistance is a Global Threat and Its Impact On Everyone
Regina Au, BioMarketing Insight, United States
Title : Distinct patterns of SARS-CoV-2 genetic variations
Jun Wan, Indiana University School of Medicine, United States
Title : The power of cultural validation when empowering community immunity
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States
Title : High dilution of Covid-19 positive throat swab shows prophylactic effect and its spectroscopic Studies
Anirban Sukul, Sukul Institute of Homeopathic Research, India
Title : Human challenge clinical trial of vaccines for infectious diseases – A necessary evil
Sudhakar Bangera, AILEEN Clinical Research Services, India
Title : Evaluating community-based vaccine initiatives with power BI
Carly Contri, American Academy of Pediatrics, United States
Title : Novel regulatory mechanisms of innate immunity and inflammation
Ping Xie, Rutgers University, United States
Title : Perception of HPV Vaccination among healthcare professionals in Morocco: Barriers and strategies for improving public acceptance
Filali Houda, Hassan 2 university, Morocco
Title : High prevalence of zero-dose children in underserved and special setting populations in ethiopia using a generalize estimating equation and concentration index analysis
Gashaw Andargie Biks, Project HOPE, Ethiopia